152 related articles for article (PubMed ID: 18771643)
1. Attitudes of men in an Australian male tolerance study towards microbicide use.
Holmes WR; Maher L; Rosenthal SL
Sex Health; 2008 Sep; 5(3):273-8. PubMed ID: 18771643
[TBL] [Abstract][Full Text] [Related]
2. Australian men's experiences during a microbicide male tolerance study.
Rosenthal SL; Holmes W; Maher L
AIDS Care; 2009 Jan; 21(1):125-30. PubMed ID: 19085229
[TBL] [Abstract][Full Text] [Related]
3. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
[TBL] [Abstract][Full Text] [Related]
4. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
[TBL] [Abstract][Full Text] [Related]
5. Clinical development of microbicides for the prevention of HIV infection.
D'Cruz OJ; Uckun FM
Curr Pharm Des; 2004; 10(3):315-36. PubMed ID: 14754390
[TBL] [Abstract][Full Text] [Related]
6. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
7. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
8. Microbicides: information, beliefs, and preferences for insertion.
Auslander BA; Perfect MM; Breitkopf DM; Succop PA; Rosenthal SL
J Womens Health (Larchmt); 2007 Dec; 16(10):1458-67. PubMed ID: 18062761
[TBL] [Abstract][Full Text] [Related]
9. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
10. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.
Weeks MR; Mosack KE; Abbott M; Sylla LN; Valdes B; Prince M
Sex Transm Dis; 2004 Nov; 31(11):682-90. PubMed ID: 15502677
[TBL] [Abstract][Full Text] [Related]
11. Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team.
Gross M; Buchbinder SP; Celum C; Heagerty P; Seage GR
Sex Transm Dis; 1998 Jul; 25(6):296-302. PubMed ID: 9662763
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of a microbicide among women and their partners in a 4-country phase I trial.
Bentley ME; Fullem AM; Tolley EE; Kelly CW; Jogelkar N; Srirak N; Mwafulirwa L; Khumalo-Sakutukwa G; Celentano DD
Am J Public Health; 2004 Jul; 94(7):1159-64. PubMed ID: 15226137
[TBL] [Abstract][Full Text] [Related]
13. Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use.
Zubowicz EA; Oakes JK; Short MB; Perfect MM; Succop PS; Rosenthal SL
J Womens Health (Larchmt); 2006 Oct; 15(8):952-61. PubMed ID: 17087619
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
[TBL] [Abstract][Full Text] [Related]
15. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
[TBL] [Abstract][Full Text] [Related]
16. Awareness and attitudes regarding microbicides and Nonoxynol-9 use in a probability sample of gay men.
Carballo-Diéguez A; O'Sullivan LF; Lin P; Dolezal C; Pollack L; Catania J
AIDS Behav; 2007 Mar; 11(2):271-6. PubMed ID: 16775772
[TBL] [Abstract][Full Text] [Related]
17. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
18. "We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.
Mantell JE; Morar NS; Myer L; Ramjee G
Am J Public Health; 2006 Jun; 96(6):1073-7. PubMed ID: 16670239
[TBL] [Abstract][Full Text] [Related]
19. High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.
Mosack KE; Weeks MR; Novick Sylla L; Abbott M
Women Health; 2005; 42(2):71-88. PubMed ID: 16537301
[TBL] [Abstract][Full Text] [Related]
20. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
